Parkinson's Disease |
DescriptionAn in-depth report on the causes, diagnosis, and treatment of Parkinson's Disease |
Alternative NamesPallidotomy |
ComplicationsParkinson's disease (PD) is not fatal, but it can reduce longevity. The disease progresses more quickly in older than younger patients, and may lead to severe incapacity within 10 to 20 years. Older patients also tend to experience freezing and greater declines in mental function and daily functioning than younger people. If PD starts without signs of tremor, it is likely to be more severe than if tremor had been present. Having other family members with PD does not appear to have any effect on the severity of the disease. Parkinson's disease can seriously impair the quality of life in any age group. The physical and emotional impact on the family should not be underestimated as the patient becomes increasingly dependent on their support. Treatment advances are increasingly effective in alleviating symptoms and even slowing progression of the disease. Taking many of the medications over time, however, can produce significant side effects. Newer agents may help reduce these occurrences. Motor ImpairmentThe negative effect of overall motor and muscle impairment on daily life can be considerable in Parkinson's patients. Some motor complications can be life-threatening.
Impact on EmotionsDepression is extremely common, affecting up to 40% of Parkinson's patients. PD poses multiple threats on the emotional health of its victims:
Effects on Thinking and Mental StatusImpaired Thinking (Cognitive Impairment). Defects in thinking, memory, language, and problem solving skills may occur early on in untreated patients or late in the course of the disease. Medications may play a role in thinking problems. In one study, for example, patients with PD were slower in detecting associations, although (unlike in Alzheimer's disease) once they discovered them they were able to apply this knowledge to other concepts. After they were taken off medication, however, they had no problems with the tasks. Dementia. Dementia is three to six times more common in the elderly Parkinson patient than in the average older adult. It is most likely to occur in older patients who have had major depression. PD marked by muscle rigidity (akinesia), rather than tremor, and early hallucinations also increase the risk for dementia. (Visual hallucinations can also occur in about a third of patients from PD medication.) Unlike in Alzheimer's, language is not usually affected in Parkinson's related dementia. Other Problems that Impair Daily LifeA number of other problems associated with Parkinson's disease affect daily life: Vision Problems. Vision is also affected, including impaired color perception and contrast sensitivity. These problems progress and can impair motor functioning. Sleep Disorders. Excessive daytime sleepiness and other sleep disorders are common in PD, both from the disease itself and from the drugs that treat it. In general, patients have a 25% higher risk for daytime sleepiness, including suddenly falling asleep, than patients with other neurologic diseases. Restless legs syndrome, an irresistible urge to move the calves, which often occurs at night, affects many PD patients. In fact, the same drugs are used for both conditions. (It should be noted that Parkinsons disease itself does not seem to increase the risk for RLS. Nor does RLS early in life predispose to Parkinsons later on. The common connection between RLS and Parkinson's disease may derive from iron deficiencies that can play a role in both conditions. Many PD patients also suffer from nighttime leg cramps. And, some of the medications cause vivid dreams as well as waking hallucinations. Impaired Sexuality. Sexuality is also reduced. This is an area not often studied but which is important for many patients' well-being. A 2000 study reported that not only did sexual dysfunction occur, but also affectionate touching and expression of feelings were reduced, even though both partners maintained a desire for intimacy. Worsened Sense of Smell. The sense of smell is impaired in about 70% of patients. |
|
|
